Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma
Related Experiment Videos
Cancer Chemotherapy Reports
|September 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.
The cancer journal from Scientific American·1998
Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.
The cancer journal from Scientific American·1998
Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.
The cancer journal from Scientific American·1998
Urinary excretion of polyamines by patients with advanced malignancy.
Cancer chemotherapy reports·1975
Chemotherapy of transplanted adenocarcinomas of the colon in mice.
Cancer chemotherapy reports·1975
Tissue disposition of 3H-actinomycin D (NSC-3053) in the rat, monkey, and dog.
Cancer chemotherapy reports·1975
Toxicology studies with cytembena (NSC-104801), an antineoplastic agent with a multispecies nephrotoxic effect.
Cancer chemotherapy reports·1975
Phase I study of corynebacterium parvum in patients with solid tumors.
Cancer chemotherapy reports·1975
Combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Cancer chemotherapy reports·1975